|国家科技期刊平台
首页|期刊导航|中国医学伦理学|《涉及人的生命科学和医学研究伦理审查办法》对生物样本的要求及对伦理审查的挑战

《涉及人的生命科学和医学研究伦理审查办法》对生物样本的要求及对伦理审查的挑战OA北大核心CSTPCD

Requirements for biological samples and challenges to ethical review under the Measures of Ethical Review of Life Sciences and Medical Research Involving Humans

中文摘要英文摘要

关于生物样本,相较于《涉及人的生物医学研究伦理审查办法》,新发布的《涉及人的生命科学和医学研究伦理审查办法》更新了定义,明确了范畴,界定了主体责任,强调了管理体系、伦理审查和知情同意.通过对比分析国内外生物样本的管理现状,发现中国对生物样本的管理和伦理审查仍存在诸多问题,生物样本的管理体系较混乱,管理的责任主体不明确,缺少行业内广泛认可的生物样本管理规范,伦理委员会缺位,伦理审查不规范,知情同意不充分或无法落实,研究结果难反馈等.因此,建议建立规范化的生物样本管理体系,进行规范有效的伦理审查和充分必要的知情同意等,以达到《涉及人的生命科学和医学研究伦理审查办法》对生物样本的要求,提升中国生物样本的管理质量.

Regarding biological samples,compared to the Measures of Ethical Review of Biomedical Research Involving Humans,the newly released Measures of Ethical Review of Life Science and Medical Research Involving Humans updated the definitions,clarified the scope,defined the responsibilities of the subject,as well as emphasized the management system,ethical review,and informed consent.By comparing and analyzing the current management status of biological samples at home and abroad,it was found that there were still many problems in the management and ethical review of biological samples in China,such as a chaotic management system of biological samples,unclear responsible entities for management,lack of widely recognized management standards of biological samples in the industry,absence of ethics committee,the non-standard ethical review,the inadequacy or inability to implement informed consent,and the difficulty in providing feedback on research results.Therefore,it is recommended to establish a standardized management system of biological samples,conduct a standardized and effective ethical review,as well as sufficient and necessary informed consent,in order to comply with the requirements of the Measures of Ethical Review of Life Science and Medical Research Involving Humans on biological samples,and enhancing the quality of the management of biological samples in China.

周维佳;周吉银

四川省肿瘤医院/电子科技大学附属肿瘤医院伦理委员会办公室,四川 成都 610041陆军军医大学第二附属医院临床医学研究中心,重庆 400037

生物样本伦理审查知情同意

biological samplesethical reviewinformed consent

《中国医学伦理学》 2024 (004)

384-391 / 8

2022年陆军军医大学人文社会科学基金重点项目"我市涉及人的健康相关研究伦理治理的现状与对策研究"(2022XRW02)

10.12026/j.issn.1001-8565.2024.04.02

评论